Neuronetics, Inc. STIM
We take great care to ensure that the data presented and summarized in this overview for Neuronetics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding STIM
View all-
Vanguard Group Inc Valley Forge, PA2.31MShares$8.95 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.74 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$5.5 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.27 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.88 Million0.19% of portfolio
-
Manatuck Hill Partners, LLC Westport, CT920KShares$3.57 Million1.7% of portfolio
-
Parian Global Management LP Pound Ridge, NY830KShares$3.22 Million8.59% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA762KShares$2.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny658KShares$2.55 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY630KShares$2.45 Million0.0% of portfolio
Latest Institutional Activity in STIM
Top Purchases
Top Sells
About STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Insider Transactions at STIM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2025
|
Steven Pfanstiel EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+41.67%
|
-
|
|
May 22
2025
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+7.61%
|
-
|
|
May 22
2025
|
Sasha Cucuz |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+1.95%
|
-
|
|
May 22
2025
|
Sheryl L Conley |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+12.28%
|
-
|
|
May 22
2025
|
Avinash Amin |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+41.38%
|
-
|
|
May 22
2025
|
Robert Cascella |
BUY
Grant, award, or other acquisition
|
Direct |
36,250
+5.9%
|
-
|
|
May 22
2025
|
Megan Rosengarten |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+17.56%
|
-
|
|
May 13
2025
|
Stephen Furlong EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
6,540
-1.57%
|
$26,160
$4.16 P/Share
|
|
May 12
2025
|
Stephen Furlong EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
193,460
-31.71%
|
$773,840
$4.27 P/Share
|
|
Mar 04
2025
|
William Andrew Macan EVP, GC, CCO and CS |
SELL
Open market or private sale
|
Direct |
377
-0.07%
|
$1,508
$4.48 P/Share
|
|
Mar 04
2025
|
Stephen Furlong EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,867
-0.31%
|
$7,468
$4.48 P/Share
|
|
Feb 24
2025
|
Keith J Sullivan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
375,000
+18.91%
|
-
|
|
Feb 24
2025
|
Stephen Furlong EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
157,500
+20.47%
|
-
|
|
Feb 24
2025
|
William Andrew Macan EVP, GC, CCO and CS |
BUY
Grant, award, or other acquisition
|
Direct |
157,500
+23.0%
|
-
|
|
Feb 19
2025
|
Keith J Sullivan President and CEO |
SELL
Open market or private sale
|
Direct |
24,440
-1.94%
|
$97,760
$4.7 P/Share
|
|
Feb 18
2025
|
Keith J Sullivan President and CEO |
SELL
Open market or private sale
|
Direct |
25,934
-2.02%
|
$103,736
$4.41 P/Share
|
|
Feb 14
2025
|
Stephen Furlong EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
17,307
-3.67%
|
$69,228
$4.11 P/Share
|
|
Feb 14
2025
|
William Andrew Macan EVP, GC, CCO and CS |
SELL
Open market or private sale
|
Direct |
18,965
-4.88%
|
$75,860
$4.11 P/Share
|
|
Feb 12
2025
|
William Andrew Macan EVP, GC, CCO and CS |
SELL
Open market or private sale
|
Direct |
12,175
-3.04%
|
$36,525
$3.83 P/Share
|
|
Feb 12
2025
|
Stephen Furlong EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,845
-2.25%
|
$32,535
$3.83 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.28M shares |
|---|---|
| Other acquisition or disposition | 267K shares |
| Open market or private purchase | 309K shares |
| Open market or private sale | 373K shares |
|---|